Innate Pharma 株価情報 (NASDAQ: IPHA)

最新ニュース Innate Pharma (NASDAQ:IPHA) 株価情報

Innate Pharma

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Innate Pharma S.A. - American Depositary Shares

Innate Pharma SA

Needham analyst Mike Matson reiterates Surmodics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRDX#NASDAQ">SRDX</a>) from Hold to Hold.

News

Reiteration

Analyst Ratings

SRDX

Needham Reiterates Hold on Surmodicsto Hold

Investors with a lot of money to spend have taken a bullish stance on Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with META, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 456 uncommon options trades for Meta Platforms.
This isn't normal.
The overall sentiment of these big-money traders is split between 47% bullish and 31%, bearish.
Out of all of the special options we uncovered, 52 are puts, for a total amount of $4,705,395, and 404 are calls, for a total amount of $51,327,020.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $180.0 and $1150.0 for Meta Platforms, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Meta Platforms stands at 1890.71, with a total volume reaching 1,328,667.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Meta Platforms, situated within the strike price corridor from $180.0 to $1150.0, throughout the last 30 days.
<h3>Meta Platforms Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738257362_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>META</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$107.6</td>
<td>$106.05</td>
<td>$106.97</td>
<td>$570.00</td>
<td>$802.9K</td>
<td>334</td>
<td align="right">259</td>
</tr>
<tr>
<td>META</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$221.85</td>
<td>$220.3</td>
<td>$220.3</td>
<td>$870.00</td>
<td>$771.4K</td>
<td>0</td>
<td align="right">48</td>
</tr>
<tr>
<td>META</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$23.35</td>
<td>$23.0</td>
<td>$23.0</td>
<td>$670.00</td>
<td>$368.0K</td>
<td>2.3K</td>
<td align="right">874</td>
</tr>
<tr>
<td>META</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$41.6</td>
<td>$40.95</td>
<td>$41.02</td>
<td>$650.00</td>
<td>$324.5K</td>
<td>4.5K</td>
<td align="right">708</td>
</tr>
<tr>
<td>META</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/28/25</td>
<td>$42.6</td>
<td>$41.1</td>
<td>$41.97</td>
<td>$650.00</td>
<td>$315.4K</td>
<td>230</td>
<td align="right">328</td>
</tr>
</tbody>
</table>

<h3>About Meta Platforms</h3>
Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.
<h3>Meta Platforms's Current Market Status</h3>
<ul>
<li>Trading volume stands at 20,027,013, with META's price up by 2.0%, positioned at $689.99.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 83 days.</li>
</ul>
<h3>Expert Opinions on Meta Platforms</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $789.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Cantor Fitzgerald keeps a Overweight rating on Meta Platforms with a target price of $790. 
&#x2A; In a positive move, an analyst from Benchmark has upgraded their rating to Buy and adjusted the price target to $820. 
&#x2A; An analyst from Piper Sandler has decided to maintain their Overweight rating on Meta Platforms, which currently sits at a price target of $775. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on Meta Platforms with a target price of $750. 
&#x2A; Consistent in their evaluation, an analyst from Rosenblatt keeps a Buy rating on Meta Platforms with a target price of $811. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Meta Platforms with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

Meta Platforms's Options: A Look at What the Big Money is Thinking

Whales with a lot of money to spend have taken a noticeably bearish stance on Riot Platforms.
Looking at options history for Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) we detected 11 trades.
If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 54% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $156,400 and 9, calls, for a total amount of $570,075.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $8.5 to $14.0 for Riot Platforms over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Riot Platforms options trades today is 4015.3 with a total volume of 19,924.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Riot Platforms's big money trades within a strike price range of $8.5 to $14.0 over the last 30 days.
<h3>Riot Platforms Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738257356_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$0.87</td>
<td>$0.86</td>
<td>$0.86</td>
<td>$12.50</td>
<td>$153.0K</td>
<td>784</td>
<td>2.1K</td>
</tr>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$2.15</td>
<td>$1.93</td>
<td>$2.1</td>
<td>$14.00</td>
<td>$126.0K</td>
<td>2.1K</td>
<td>602</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$0.27</td>
<td>$0.25</td>
<td>$0.29</td>
<td>$12.00</td>
<td>$110.6K</td>
<td>14.2K</td>
<td>10.6K</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$0.73</td>
<td>$0.72</td>
<td>$0.72</td>
<td>$12.00</td>
<td>$76.0K</td>
<td>3.7K</td>
<td>1.8K</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$3.3</td>
<td>$3.2</td>
<td>$3.25</td>
<td>$10.00</td>
<td>$65.0K</td>
<td>4.8K</td>
<td>220</td>
</tr>
</tbody>
</table>

<h3>About Riot Platforms</h3>
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining; Data Center Hosting and Engineering. It generates maximum revenue from the Bitcoin Mining segment which generates revenue from the Bitcoin the company earns through its mining activities.
Having examined the options trading patterns of Riot Platforms, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Riot Platforms's Current Market Status</h3>
<ul>
<li>With a trading volume of 25,745,058, the price of RIOT is up by 3.74%, reaching $11.64.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 21 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Riot Platforms</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $16.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Needham persists with their Buy rating on Riot Platforms, maintaining a target price of $16. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Riot Platforms options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

RIOT

What the Options Market Tells Us About Riot Platforms

High-rolling investors have positioned themselves bullish on Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in CMG often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for Chipotle Mexican Grill. This is not a typical pattern.
The sentiment among these major traders is split, with 37% bullish and 25% bearish. Among all the options we identified, there was one put, amounting to $78,750, and 7 calls, totaling $394,487.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $51.0 to $60.0 for Chipotle Mexican Grill over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Chipotle Mexican Grill's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Chipotle Mexican Grill's significant trades, within a strike price range of $51.0 to $60.0, over the past month.
<h3>Chipotle Mexican Grill 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738257351_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$12.9</td>
<td>$12.6</td>
<td>$12.6</td>
<td>$60.00</td>
<td>$127.4K</td>
<td>695</td>
<td align="right">114</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$5.05</td>
<td>$4.95</td>
<td>$4.99</td>
<td>$56.00</td>
<td>$99.9K</td>
<td>1.4K</td>
<td align="right">231</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/07/25</td>
<td>$1.25</td>
<td>$1.24</td>
<td>$1.25</td>
<td>$57.00</td>
<td>$78.7K</td>
<td>1.6K</td>
<td align="right">655</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/07/25</td>
<td>$3.05</td>
<td>$2.95</td>
<td>$3.05</td>
<td>$58.00</td>
<td>$40.5K</td>
<td>1.1K</td>
<td align="right">314</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/14/25</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.83</td>
<td>$57.00</td>
<td>$38.3K</td>
<td>529</td>
<td align="right">102</td>
</tr>
</tbody>
</table>

<h3>About Chipotle Mexican Grill</h3>
Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $9.9 billion in 2023. The Mexican concept is almost exclusively company-owned, with just two license stores opearted through a master franchise relationship with Alshaya Group in the Middle East. It had a footprint of nearly 3,440 stores at the end of 2023, heavily indexed to the United States, although it maintains a small presence in Canada, the UK, France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Having examined the options trading patterns of Chipotle Mexican Grill, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Chipotle Mexican Grill Standing Right Now?</h3>
<ul>
<li>With a trading volume of 2,309,477, the price of CMG is up by 1.03%, reaching $58.87.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 5 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Chipotle Mexican Grill</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $67.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Chipotle Mexican Grill, targeting a price of $63. 
&#x2A; An analyst from Wedbush downgraded its action to Outperform with a price target of $69. 
&#x2A; An analyst from Raymond James persists with their Outperform rating on Chipotle Mexican Grill, maintaining a target price of $69. 
&#x2A; An analyst from Citigroup persists with their Buy rating on Chipotle Mexican Grill, maintaining a target price of $69. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Chipotle Mexican Grill, targeting a price of $69. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Chipotle Mexican Grill, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

A Closer Look at Chipotle Mexican Grill's Options Market Dynamics

B of A Securities analyst Justin Post maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Buy and raises the price target from $710 to $765.

Price Target

B of A Securities Maintains Buy on Meta Platforms, Raises Price Target to $765

RBC Capital analyst Irene Nattel reiterates Saputo (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SAP#TSX">SAP</a>) with a Outperform and maintains C$38 price target.

TSX:SAP

RBC Capital Reiterates Outperform on Saputo, Maintains C$38 Price Target

Murphy Oil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUR#NYSE">MUR</a>) shares are trading lower on Thursday after the company reported 2024 fiscal-year fourth-quarter earnings before <a href="https://www.benzinga.com//node/43330142">the market opened</a>.
What To Know: Murphy reported revenue of $670.96 million, missing analysts estimate of $741.18 million. In addition, the company reported adjusted earnings per share of 35 cents, missing analysts estimate of 57 cents.
Furthermore, Murphy reported net debt at about $850 million, the company&#8217;s lowest in over a decade. It reported adjusted EBITDA of $321 million.
&#8220;I am pleased that in 2024, we continued to focus on our priorities of Delever, Execute, Explore and Return. As a result, we achieved Murphy 3.0 of our capital allocation framework, strengthened our balance sheet, increased our liquidity, made two impactful discoveries and advanced our Lac Da Vang field development project in Vietnam,&#8221; said Eric M. Hambly, President and CEO of Murphy.
Murphy issued guidance for the 2025 fiscal-year. It sees capital expenditure of between $1.13 billion and $1.28 billion.
Related Link: <a href="https://www.benzinga.com/25/01/43342228/servicenow-stock-is-tumbling-thursday-whats-going-on">ServiceNow Stock Is Tumbling Thursday: What&#8217;s Going On?</a>
MUR Price Action: At the time of writing, Murphy shares are trading 6.24% lower at $27.35, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

Movers

What's Going On With Murphy Oil Stock Thursday?

Goldman Sachs analyst Susan Maklari reiterated a <a href="https://www.benzinga.com/quote/WHR/analyst-ratings">Buy rating</a> on the shares of Whirlpool Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>) with a price target of $138.
Whirlpool reported adjusted <a href="https://www.benzinga.com/pressreleases/25/01/n43318720/whirlpool-announces-fourth-quarter-and-full-year-results-provides-2025-guidance">fourth-quarter EPS of $4.57</a>, exceeding the analyst&#8217;s forecast of $4.08 and the FactSet consensus of $4.34. 
The stronger-than-expected performance relative to the analyst&#8217;s model was driven by a lower adjusted tax rate, which added $1.61 to the results, as well as interest expenses and other factors contributing an additional $0.22. 
Revenue dropped by 18.7%, slightly better than the analyst&#8217;s estimate of -18.9%, adding $0.01. However, this was partially offset by an adjusted EBIT margin 118 basis points lower than the analyst&#8217;s estimate of 6.0%, which reduced earnings by $1.35.
Overall, the results were influenced by a significant inventory reduction at a major North American retailer and ongoing weakness in discretionary spending, which pressured product mix and margins. 
Looking ahead, the 2025 adjusted EPS guidance was set at approximately $10, below the analyst&#8217;s forecast of $10.75 and the consensus estimate of $11.46.
Revenues in the North America MDA segment declined by 1% year-over-year, better than the analyst&#8217;s expected drop of 2%, as the analyst estimated that volumes were relatively stable while price/mix challenges remained consistent with the previous quarter.
Small Domestic Appliance revenues grew by 6%, falling short of the analyst&#8217;s 8% estimate, as a challenging market environment partially offset strong direct-to-consumer sales and new product introductions.
Additionally, investments in marketing and new products caused the segment's margin to fall 350 basis points, declining by 127 basis points year-over-year to 12.5%, said the analyst.
The company plans to sell about 31% of its stake in Whirlpool India for $550-$600 million, with the transaction expected to be completed by mid- to late 2025.
Management intends to use the proceeds to reduce debt by around $700 million in 2025 and refinance $1.1-$1.2 billion in upcoming maturities.
The analyst will be looking for updates on the U.S. demand given the macro backdrop, the success of recent new product introductions, key factors to margins including price realization, inflation, and cost reductions, and the impact of potential trade actions.
WHR Price Action: Whirpool shares are trading lower by 17.58% at $106.96 at publication Thursday.
Read Next: <a href="https://www.benzinga.com/news/earnings/25/01/43335015/ups-q4-earnings-major-customer-volume-cut-raises-jitters-stock-tanks"> • UPS Q4 Earnings: Major Customer Volume Cut Raises Jitters, Stock Tanks</a>
Photo: Grzegorz Czapski via Shutterstock

Global

Opinion

Trading Ideas

General

Whirlpool Inventory Reduction, Low Discretionary Spending Led To Q4 Revenue Miss, Says Analyst

The Board of Directors of <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4352168-1&amp;h=655529854&amp;u=http%3A%2F%2Fwww.jacobs.com%2F&amp;a=Jacobs">Jacobs</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) has declared a quarterly cash dividend payable to shareholders in the amount of $0.32 per share of Jacobs common stock,&nbsp;an increase of 10% from its previous quarterly dividend of $0.29. This dividend will be paid on March 21, 2025, to shareholders of record as of the close of business on Feb. 21, 2025.

Dividends

Jacobs Increases Quarterly Dividend From $0.29 To $0.32 Per Share

ORCL

Live On CNBC, Jim Labenthal Announces Trimmed Oracle Position

RBC Capital analyst Jon Arfstrom reiterates UMB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UMBF#NASDAQ">UMBF</a>) with a Sector Perform and maintains $128 price target.

UMBF

RBC Capital Reiterates Sector Perform on UMB Financial, Maintains $128 Price Target

Trane Technologies plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TT#NYSE">TT</a>) reported fourth-quarter revenue growth of 10% year-over-year <a href="https://www.benzinga.com/earnings">to $4.87 billion</a>. 
The company surpassed the consensus of $4.79 billion.
Bookings increased&nbsp;3% Y/Y to&nbsp;$4.67 billion&nbsp;in the quarter. Enterprise reported a&nbsp;10% Y/Y increase in both revenues and organic revenues.
The backlog totaled&nbsp;$6.75 billion at the end of 2024. Adjusted EBITDA rose&nbsp;17% Y/Y to&nbsp;$894 million, with a margin expansion of 110&nbsp;bps Y/Y to&nbsp;18.3%.
Adjusted&nbsp;EPS of&nbsp;$2.61 (+20% Y/Y) surpassed&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">the street view of&nbsp;$2.54</a>.
As of Dec. 31, 2024: 
<ul>
<li>Operating cash flow from continuing operating activities reached $3.178 billion</li>
<li>Free cash flow amounted to $2.8 billion.</li>
<li>Cash and equivalents stood at $1.59 billion.</li>
<li>In 2024, the Swords, Ireland-based company deployed or committed $2.5 billion in capital. </li>
<li>The deployment includes $760 million for dividends and $1.3 billion for share repurchases.</li>
</ul>
Trane Technologies plans to deploy 100% of excess cash to shareholders over time.
2025 Outlook: Trane Technologies expects an FY25 organic revenue growth outlook of 7%-8% and adjusted EPS of<a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener"> $12.70-$12.90 (vs. street view of $12.69)</a>.
Dave Regnery, chair and CEO of Trane Technologies said, &#8220;We achieved record financial results with strong organic revenue growth of 12%, powerful free cash flow conversion of 109% and adjusted earnings per share growth of 24% – our fourth consecutive year of earnings per share growth of 20% or more.&#8221;
&#8221;Since launching Trane Technologies in 2020, we have delivered a compound annual revenue growth rate of 12%, realized free cash flow conversion of 108% of adjusted net earnings, expanded EBITDA margins by 400 basis points and deployed approximately $12 billion of capital.&#8221;
Investors can gain exposure to the stock via&nbsp;Invesco Building &amp; Construction ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKB#NYSE">PKB</a>) and&nbsp;TCW Transform Supply Chain ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUPP#NYSE">SUPP</a>).
Price Action: Trane Technologies shares are down 0.49% at $362.22 premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42927075/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a></li>
</ul>
Image: Shutterstock

Earnings

Equities

Large Cap

Guidance

SUPP

Trane Technologies Reports Strong Q4, Backlog Reaches $6.75 Billion As Demand Remains Robust

BMO Capital analyst Simeon Siegel maintains VF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) with a Market Perform and raises the price target from $14 to $25.

BMO Capital Maintains Market Perform on VF, Raises Price Target to $25

RBC Capital analyst Tom Narayan reiterates Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Outperform and maintains $440 price target.

TSLA

RBC Capital Reiterates Outperform on Tesla, Maintains $440 Price Target

BMO Capital analyst Brian Pitz maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Market Perform and raises the price target from $530 to $610.

BMO Capital Maintains Market Perform on Meta Platforms, Raises Price Target to $610

RBC Capital analyst Jonathan Atkin maintains T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) with a Sector Perform and raises the price target from $240 to $245.

TMUS

RBC Capital Maintains Sector Perform on T-Mobile US, Raises Price Target to $245

FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) stock is trading lower on Thursday in sympathy with United Postal Service (UPS), which fell after it reported 2024 fiscal-year <a href="https://www.benzinga.com/news/earnings/25/01/43335015/ups-q4-earnings-major-customer-volume-cut-raises-jitters-stock-tanks">fourth-quarter earnings. </a>
UPS reported revenue of $25.30 billion, missing analysts estimate of $25.41 billion. In addition, the company reported adjusted earnings per share of $2.75, beating analysts estimate of $2.53.
Additionally, UPS reported an operating profit of $8.5 billion and an operating margin of 9.3%. The company reported cash from operations of $10.1 billion.
UPS announced it will reduce its volume with its largest customer by over 50% before the second half of 2026. The company announced this as part of a series of strategic actions it is implementing.
&#8220;We are making business and operational changes that, along with the foundational changes we&#8217;ve already made, will put us further down the path to becoming a more profitable, agile and differentiated UPS that is growing in the best parts of the market,&#8221; said Carol Tomé, CEO of UPS.
FedEx may be trading lower in sympathy with UPS, as investors might see this as an indication of broader industry challenges. This could include weaker demand or pricing pressures that may affect FedEx as well.
See Also: <a href="https://www.benzinga.com/25/01/43340144/northrop-grummans-q4-sales-stagnate-space-systems-struggles-but-margins-and-eps-improve">Northrop Grumman&#8217;s Q4 Sales Stagnate, Space Systems Struggles, But Margins And EPS Improve</a>
FDX Price Action: At the time of writing, FedEx stock is trading 3.23% lower at $266.18, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock.

What's Going On With FedEx Shares Thursday?

BMO Capital analyst Jeffrey Silber maintains Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) with a Outperform and raises the price target from $122 to $134.

BMO Capital Maintains Outperform on Stride, Raises Price Target to $134

<h3>Gainers</h3>
<ul>
<li>Acadian Asset Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAMI#NYSE">AAMI</a>) stock rose 18.4% to $29.99 during Thursday's pre-market session. The market value of their outstanding shares is at $1.1 billion. </li>
<li>Lake Shore Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSBK#NASDAQ">LSBK</a>) stock moved upwards by 11.86% to $14.99. The company's market cap stands at $85.9 million. As per the news, the Q4 earnings report came out 4 days ago. </li>
<li>Rithm Property (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPT#NYSE">RPT</a>) stock increased by 10.13% to $3.15. The company's market cap stands at $143.0 million. </li>
<li>Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) shares moved upwards by 10.01% to $58.0. The market value of their outstanding shares is at $5.2 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Highest Performances (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPH#NASDAQ">HPH</a>) shares increased by 9.86% to $0.27. The market value of their outstanding shares is at $66.3 million. </li>
<li>Flagstar Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLG#NYSE">FLG</a>) shares increased by 9.47% to $10.51. The company's market cap stands at $4.3 billion. As per the press release, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>B. Riley Financial, Inc. - 5.00% Senior Notes due 2026 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RILYG#NASDAQ">RILYG</a>) shares fell 56.4% to $5.02 during Thursday's pre-market session. </li>
<li>Coincheck Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNCK#NASDAQ">CNCK</a>) shares fell 17.75% to $7.0. The company's market cap stands at $907.9 million. </li>
<li>Eason Technology (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DXF#AMEX">DXF</a>) shares decreased by 10.5% to $20.56. The company's market cap stands at $4.7 million. </li>
<li>First Northwest Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNWB#NASDAQ">FNWB</a>) shares declined by 8.16% to $9.8. The company's market cap stands at $86.3 million. The company's, Q4 earnings came out yesterday. </li>
<li>DigiAsia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAAS#NASDAQ">FAAS</a>) shares decreased by 7.41% to $0.5. The company's market cap stands at $30.3 million. </li>
<li>mF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFI#NASDAQ">MFI</a>) stock declined by 6.55% to $0.7. The company's market cap stands at $9.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAMI

CNCK

FAAS

FNWB

LSBK

RILYG

12 Financials Stocks Moving In Thursday's Pre-Market Session

<a href="https://greenidge.com/wp-content/uploads/2025/01/GREE-Power-to-Grid-January-2025-Cold-Snap-1.30.25.pdf" title="https://greenidge.com/wp-content/uploads/2025/01/GREE-Power-to-Grid-January-2025-Cold-Snap-1.30.25.pdf">https://greenidge.com/wp-content/uploads/2025/01/GREE-Power-to-Grid-January-2025-Cold-Snap-1.30.25.pdf</a>

GREE

Greenidge Generation Announces More Than 90% Of The Power Generation From Its Dresden, NY Facility Was Sent To The Local Electrical Grid During Last Week's Peak Extreme Cold Weather And Peak Demand On The Local Grid.

Innate Pharma (IPHA) announced the publication in Science Immunology of preclinical data demonstrating the potential of IPH6501, Innate's proprieta...

Innate Pharma publishes IPH6501 data in Science Immunology

Innate Pharma: Looking Like A Company We'll Regret Ignoring

Innate Pharma (IPHA) with the Institute for Follicular Lymphoma, or IFLI, announced that they have entered into an agreement to clinically study th...

Innate Pharma partners with IFLI to study IPH6501, to receive $3M upfront

Innate Pharma presents lacutamab improved health-related quality of life data at ASH 2024

Innate Pharma (IPHA) announced new data highlighting the quality-of-life improvements observed in patients with cutaneous T-cell lymphoma, or CTCL,...

Innate Pharma announces new data from TELLOMAK study

Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Innate Pharma (IPHA – Research Report) and keeping the price target ...

Positive Outlook for Innate Pharma: Buy Rating Supported by Promising Lacutamab Phase 2 Results and Strong Financial Position

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:&nbsp...

Biotech Alert: Searches spiking for these stocks today

Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on Innate Pharma (IPHA – Research Report), retaining the price target of ...

Innate Pharma: Promising Pipeline and Strategic Initiatives Support Buy Rating

In a report released on January 17, Sean Lee from Citi reiterated a Buy rating on Innate Pharma (IPHA – Research Report), with a price target of $1...

Citi Keeps Their Buy Rating on Innate Pharma (IPHA)

Innate Pharma (IPHA) announced the first patient was dosed in its Phase 1 study, investigating the safety and tolerability of IPH4502, an Antibody-...

Innate Pharma doses first patient in IPH4502 study

AGIO

CMRX

IPHA

IPHYF

MCRB

Press Releases

Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501

Innate Pharma Releases Its 2025 Financial Calendar

Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024

Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma

Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma

Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Innate Pharma Announces Transformative Strategy to Accelerate Growth

Number of Shares and Voting Rights of Innate Pharma as of December 31, 2024

Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York

Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid Tumors

Comments

Innate Pharma

ニュース

最新ニュース Innate Pharma (NASDAQ:IPHA) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル